| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | -0.18 | 0.2 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | -0.16 | 0.2 |
| mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | -0.16 | 0.05 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.14 | 0.7 |
| mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | -0.11 | 0.03 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | -0.099 | 0.1 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | -0.094 | 0.3 |
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.02 |
| mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | -0.081 | 0.1 |
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.078 | 0.5 |